Glenmede Trust’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $59.6K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $209K | Sell |
|
|||||
|
2020
Q4 | $598K | Buy |
|
|||||
|
2020
Q3 | $624K | Sell |
|
|||||
|
2020
Q2 | $535K | Sell |
|
|||||
|
2020
Q1 | $371K | Hold |
|
|||||
|
2019
Q4 | $371K | Sell |
|
|||||
|
2019
Q3 | $386 | Buy |
|
|||||
|
2019
Q2 | $354 | Sell |
|
|||||
|
2019
Q1 | $31K | Buy |
|
|||||
|
2018
Q4 | $30.6K | Sell |
|
|||||
|
2018
Q3 | $52.5M | Sell |
|
|||||
|
2018
Q2 | $47.1M | Sell |
|
|||||
|
2018
Q1 | $45.7M | Hold |
|
|||||
|
2017
Q4 | $45.7M | Sell |
|
|||||
|
2017
Q3 | $61.2M | Sell |
|
|||||
|
2017
Q2 | $50M | Hold |
|
|||||
|
2017
Q1 | $50M | Buy |
|
|||||
|
2016
Q4 | $48.3M | Buy |
|
|||||
|
2016
Q3 | $41.1M | Buy |
|
|||||
|
2016
Q2 | $26.8M | Buy |
|
|||||
|
2016
Q1 | $27.2M | Sell |
|
|||||
|
2015
Q4 | $31.6M | Sell |
|
|||||
|
2015
Q3 | $24.9M | Buy |
|
|||||
|
2015
Q2 | $23.5M | Sell |
|
|||||
|
2015
Q1 | $20.7M | Buy |
|
|||||
|
2014
Q4 | $19.4M | Buy |
|
|||||
|
2014
Q3 | $14.2M | Buy |
|
|||||
|
2014
Q2 | $13M | Buy |
|
|||||
|
2014
Q1 | $10.5M | Buy |
|